Interventional Spine, Inc. Acquires Intellectual Property for New PERCUTANEOUS Spinal Disc Replacement System

Interventional Spine, Inc. today announced that it has entered an agreement with Dr. Rudolf Morgenstern for the acquisition of all intellectual property, product prototypes and test data of Dr. Morgenstern’s Percutaneous Nucleus Scaffolding System (PNSS). The PNSS System, when used with Interventional Spine’s existing PercuDyn System, is intended to provide a totally percutaneous procedure to replace the current highly invasive, open surgical total disc replacement procedure using conventional artificial spinal discs.

“Interventional Spine, Inc. is dedicated to improving the delivery of spine therapy to patients suffering chronic back pain worldwide. The present standard of care subjects patients to invasive, and often painful, surgical procedures. Interventional Spine’s focus is to replace this practice with percutaneous techniques, benefiting both patients and medical practitioners,” said Walter A. Cuevas, Interventional Spine’s CEO. “The spine therapy market is the last major surgical discipline yet to see this transformation away from 30-year old surgical techniques that subject patients to major trauma, extended operating room procedure times, high costs, extended post procedure hospital stays, and relatively high rates of complications, as well as related rehabilitation hurdles,” Mr. Cuevas continued.

Dr. Rudolf Morgenstern, Director and Chief Surgeon of the Morgenstern Institute of Endoscopic Spine Surgery at the Centro Medico Teknon in Barcelona, Spain, is one of Europe’s most experienced minimally invasive and endoscopic spine surgeons. Dr Morgenstern also holds a Ph.D. in Mechanical Engineering. Commenting on the combination of PNSS with the PercuDyn technology, he said “My work is precisely in line with Interventional Spine’s objectives, focus, capabilities and attitudes. At the Morgenstern Institute, we strive to match the best patient outcome possible with innovative and potentially disruptive approaches to such areas as disc replacement therapy,” he continued. “This is a very exciting announcement and I believe hastens the dawn of a new day in spine therapy. We have seen how relatively small companies initiate worldwide commercialization of breakthrough medical innovations. Companies such as Interventional Spine are not wedded to today’s paradigms, but rather to tomorrow’s vision and opportunities,” Dr. Morgenstern concluded.

The details of the agreement were not announced.

Interventional Spine, Inc. is a privately held company based in Irvine, California that designs, develops, and markets patented implantable devices for the spine that can be deployed via percutaneous techniques, supported by the Company’s unique product introduction systems, providing benefits to patients, surgeons, and hospitals. More information on the Company and its products can be found at:


Share your thoughts

Your email address will not be published. Required fields are marked *